Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for PatientsBusiness Wire • 01/21/25
Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental UpdateSeeking Alpha • 01/15/25
Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical CareBusiness Wire • 01/14/25
Tempus AI Stock Falls Despite Collaboration Announcement With GenialisZacks Investment Research • 01/09/25
Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker AlgorithmsBusiness Wire • 01/08/25
Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now?Zacks Investment Research • 01/07/25
5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & MoreZacks Investment Research • 12/30/24
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdownCNBC • 12/24/24
Tempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare SolutionsBusiness Wire • 12/18/24
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF DeviceBusiness Wire • 12/17/24
Tempus AI: Pioneering The Future Of Precision Medicine Through AI-Driven InnovationSeeking Alpha • 11/12/24
Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR®Business Wire • 11/12/24